Novo Nordisk Launches New Program To Recognize People With Type 2 Diabetes Who Give Back To Their Communities

Novo Nordisk Launches New Program To Recognize People With Type 2 Diabetes Who
                        Give Back To Their Communities

PR Newswire

PRINCETON, N.J., Jan. 22, 2013

PRINCETON, N.J., Jan. 22, 2013 /PRNewswire/ --Novo Nordisk, a world leader in
diabetes care, today kicked off the first NovoLog^® Community Star contest. As
part of the program, type 2 diabetes patients successfully managing their
blood sugar with NovoLog^® (insulin aspart [rDNA origin] injection) are
invited to visit and tell us how they're giving back to their
local communities. 

To view the multimedia assets associated with this release, please click:

(Photo: )

Now through March 15, NovoLog^® patients can submit their story and photo
online for the chance to be crowned a NovoLog^® Community Star.* Finalists
will be selected by a panel of judges, and each will receive a $5,000 donation
to a local diabetes-related organization of their choice. One grand prize
winner will also receive a one-year online subscription to Weight Watchers^®
to help with their diabetes management.

Two-time NFL Super Bowl Champion and NovoLog^® patient Kendall Simmons has
partnered with Novo Nordisk to encourage people to get involved. Diagnosed in
2003, Kendall has been very active in his Alabama community, hosting an annual
"Swing4Diabetes" charity golf tournament to raise money for a nearby diabetes
and nutrition center.

"There is an army of unsung diabetes heroes out there, and I'm thrilled to
partner with Novo Nordisk to find them," said Simmons. "Whether coaching a
little league team, volunteering at a soup kitchen, or fundraising for
charity, whatever it is that you're able to do to give back to your community,
then we want to hear from you."

All NovoLog^® Community Star finalists will have the choice of a $5,000
donation made in their name to one of several third party organizations,
including the American Diabetes Association, Produce for Better Health
Foundation, and Insulindependence. Entries will be accepted for approximately
eight weeks, and finalists will be announced later this year.

"We are excited to launch the first nation-wide NovoLog^® Community Star
program," said Camille Lee, corporate vice president, Diabetes Marketing. "Our
company was founded for people with diabetes and this contest is a great way
to shine a local light on all of the positive work they can accomplish." 

Official Rules for submission are available by visiting If
you have type 2 diabetes, or know someone who does, go online to share your
inspiring story and learn more about insulin treatment and delivery options

Weight Watchers^® is a registered trademark of Weight Watchers International,

Indications and Usage
What is NovoLog^® (insulin aspart [rDNA origin] injection)?

  oNovoLog^® is a man-made insulin used to control high blood sugar in adults
    and children with diabetes mellitus.

Important Safety Information
Who should not use NovoLog^®?

  oDo not use NovoLog^® if your blood sugar is too low (hypoglycemia) or you
    are allergic to any of its ingredients.

What should I tell my healthcare provider before taking NovoLog^®?

  oAbout all of your medical conditions, including liver or kidney problems.
  oIf you are pregnant, breastfeeding, or plan to do either.
  oAbout all prescription and nonprescription medicines you take, including
    supplements, as your dose may need to change.

How should I take NovoLog^®?

  oEat a meal within 5 to 10 minutes after using NovoLog^®, a fast-acting
    insulin, to avoid low blood sugar. Do not inject NovoLog^® if you do not
    plan to eat right after your injection or bolus pump infusion.
  oDo not mix NovoLog^® with any other insulin when used in a pump or with
    any insulin other than NPH when used with injections by syringe.
  oDo not change your dose or type of insulin unless you are told to by your
    healthcare provider.
  oDo not share needles, insulin pens, or syringes.
  oCheck your blood sugar levels as directed by your healthcare provider.

What should I consider while using NovoLog^®?

  oAlcohol, including beer and wine, may affect your blood sugar.
  oBe careful when driving a car or operating machinery. You may have
    difficulty concentrating or reacting if you have low blood sugar. Talk to
    your healthcare provider if you often have low blood sugar or no warning
    signs of low blood sugar.

What are the possible side effects of NovoLog^®?

  oLow blood sugar, including when too much is taken. Some symptoms include
    sweating, shakiness, confusion, and headache. Severe low blood sugar can
    cause unconsciousness, seizures, and death.
  oSerious allergic reactions may occur. Get medical help right away, if you
    develop a rash over your whole body, have trouble breathing, a fast
    heartbeat, or sweating.
  oOther side effects include injection site reactions (like redness,
    swelling, and itching), skin thickening or pits at the injection site,
    swelling of your hands and feet, vision changes, low potassium in your
    blood, and weight gain.

*Certain restrictions apply. See official rules for entry information.

Please visit for Prescribing Information.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89
years of innovation and leadership in diabetes care. The company also has
leading positions within hemophilia care, growth hormone therapy and hormone
replacement therapy. For more information, visit or follow
our news in the US on Twitter: @NovoNordiskUS

About Diabetes
In the United States, 25.8 million people have diabetes[i], a condition in
which the body does not produce enough or properly use insulin, the hormone
needed to convert sugar, starches and other food into energy needed for daily

NovoLog^® is a registered trademark of Novo Nordisk A/S.

[i] 2011 National Diabetes Fact Sheet. Centers for Disease Control Website. Accessed November 28,

© 2013 Novo Nordisk All rights reserved. 1112-00012570-1 January 2013

SOURCE Novo Nordisk Inc.

Contact: Sarah Spielvogel, Novo Nordisk, +1-609-786-4278,
Press spacebar to pause and continue. Press esc to stop.